{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:38:58Z","timestamp":1790991538221,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:00:00Z","timestamp":1548115200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31800631"],"award-info":[{"award-number":["31800631"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31800638"],"award-info":[{"award-number":["31800638"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12951-019-0446-6","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T09:38:10Z","timestamp":1548236290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["A milk-based self-assemble rotavirus VP6\u2013ferritin nanoparticle vaccine elicited protection against the viral infection"],"prefix":"10.1186","volume":"17","author":[{"given":"Zhipeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuiqing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuhang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kongwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaojun","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengchao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deshun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,22]]},"reference":[{"issue":"52","key":"446_CR1","doi-asserted-by":"publisher","first-page":"6170","DOI":"10.1016\/j.vaccine.2013.05.037","volume":"31","author":"WHO","year":"2013","unstructured":"WHO. Rotavirus vaccines WHO position paper: January 2013-Recommendations. Vaccine. 2013;31(52):6170\u20131.","journal-title":"Vaccine"},{"issue":"12","key":"446_CR2","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1097\/INF.0b013e31814521cb","volume":"26","author":"MG Goveia","year":"2007","unstructured":"Goveia MG, Rodriguez ZM, Dallas MJ, Itzler RF, Boslego JW, Heaton PM, et al. Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants. Pediatr Infect Dis J. 2007;26(12):1099\u2013104.","journal-title":"Pediatr Infect Dis J."},{"issue":"1","key":"446_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa052434","volume":"354","author":"GM Ruiz-Palacios","year":"2006","unstructured":"Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354(1):11\u201322.","journal-title":"N Engl J Med"},{"issue":"5","key":"446_CR4","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1586\/erv.12.28","volume":"11","author":"V Pliaka","year":"2012","unstructured":"Pliaka V, Kyriakopoulou Z, Markoulatos P. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis. Expert Rev Vaccines. 2012;11(5):609\u201328.","journal-title":"Expert Rev Vaccines."},{"key":"446_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2016.05.001","volume":"120","author":"CP Karch","year":"2016","unstructured":"Karch CP, Burkhard P. Vaccine technologies: from whole organisms to rationally designed protein assemblies. Biochem Pharmacol. 2016;120:1\u201314.","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"446_CR6","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1053\/j.gastro.2009.02.076","volume":"136","author":"HB Greenberg","year":"2009","unstructured":"Greenberg HB, Estes MK. Rotaviruses: from pathogenesis to vaccination. Gastroenterology. 2009;136(6):1939\u201351.","journal-title":"Gastroenterology"},{"issue":"4","key":"446_CR7","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s007050050674","volume":"145","author":"FR Esquivel","year":"2000","unstructured":"Esquivel FR, Lopez S, Guitierrez-x L, Arias C. The internal rotavirus protein VP6 primes for an enhanced neutralizing antibody response. Arch Virol. 2000;145(4):813\u201325.","journal-title":"Arch Virol"},{"issue":"27","key":"446_CR8","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1016\/S0264-410X(02)00315-8","volume":"20","author":"AH Choi","year":"2002","unstructured":"Choi AH, McNeal MM, Basu M, Flint JA, Stone SC, Clements JD, et al. Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses. Vaccine. 2002;20(27):3310\u201321.","journal-title":"Vaccine."},{"issue":"5258","key":"446_CR9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.272.5258.104","volume":"272","author":"JW Burns","year":"1996","unstructured":"Burns JW, Siadat-Pajouh M, Krishnaney AA, Greenberg HB. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science. 1996;272(5258):104\u20137.","journal-title":"Science"},{"issue":"2","key":"446_CR10","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/0042-6822(90)90357-W","volume":"178","author":"M Bremont","year":"1990","unstructured":"Bremont M, Chabanne-Vautherot D, Vannier P, McCrae MA, Cohen J. Sequence analysis of the gene (6) encoding the major capsid protein (VP6) of group C rotavirus: higher than expected homology to the corresponding protein from group A virus. Virology. 1990;178(2):579\u201383.","journal-title":"Virology"},{"issue":"16","key":"446_CR11","doi-asserted-by":"publisher","first-page":"8110","DOI":"10.1128\/JVI.76.16.8110-8117.2002","volume":"76","author":"I Schwartz-Cornil","year":"2002","unstructured":"Schwartz-Cornil I, Benureau Y, Greenberg H, Hendrickson BA, Cohen J. Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins. J Virol. 2002;76(16):8110\u20137.","journal-title":"J Virol"},{"issue":"45","key":"446_CR12","doi-asserted-by":"publisher","first-page":"8126","DOI":"10.1016\/j.vaccine.2011.08.026","volume":"29","author":"V Blazevic","year":"2011","unstructured":"Blazevic V, Lappalainen S, Nurminen K, Huhti L, Vesikari T. Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis. Vaccine. 2011;29(45):8126\u201333.","journal-title":"Vaccine."},{"issue":"29","key":"446_CR13","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1016\/j.vaccine.2015.05.026","volume":"33","author":"S Jalilvand","year":"2015","unstructured":"Jalilvand S, Marashi SM, Shoja Z. Rotavirus VP6 preparations as a non-replicating vaccine candidates. Vaccine. 2015;33(29):3281\u20137.","journal-title":"Vaccine."},{"issue":"3","key":"446_CR14","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/cmdc.201200487","volume":"8","author":"PM Moyle","year":"2013","unstructured":"Moyle PM, Toth I. Modern subunit vaccines: development, components, and research opportunities. ChemMedChem. 2013;8(3):360\u201376.","journal-title":"ChemMedChem"},{"issue":"5","key":"446_CR15","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/nrd2224","volume":"6","author":"AW Purcell","year":"2007","unstructured":"Purcell AW, McCluskey J, Rossjohn J. More than one reason to rethink the use of peptides in vaccine design. Nat Rev Drug Discov. 2007;6(5):404\u201314.","journal-title":"Nat Rev Drug Discov."},{"issue":"7456","key":"446_CR16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature12202","volume":"499","author":"M Kanekiyo","year":"2013","unstructured":"Kanekiyo M, Wei CJ, Yassine HM, McTamney PM, Boyington JC, Whittle JR, et al. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature. 2013;499(7456):102\u20136.","journal-title":"Nature"},{"issue":"2","key":"446_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1089\/ind.2006.2.143","volume":"2","author":"CQ Li","year":"2006","unstructured":"Li CQ, Soistman E, Carter DC. Ferritin nanoparticle technology. A new platform for antigen presentation and vaccine development. Ind Biotechnol. 2006;2(2):143\u20137.","journal-title":"Ind Biotechnol"},{"issue":"6","key":"446_CR18","doi-asserted-by":"publisher","first-page":"1537S","DOI":"10.1093\/ajcn\/77.6.1537S","volume":"77","author":"B Lonnerdal","year":"2003","unstructured":"Lonnerdal B. Nutritional and physiologic significance of human milk proteins. Am J Clin Nutr. 2003;77(6):1537S\u201343S.","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"446_CR19","doi-asserted-by":"publisher","first-page":"712S","DOI":"10.3945\/ajcn.113.071993","volume":"99","author":"B Lonnerdal","year":"2014","unstructured":"Lonnerdal B. Infant formula and infant nutrition: bioactive proteins of human milk and implications for composition of infant formulas. Am J Clin Nutr. 2014;99(3):712S\u20137S.","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"446_CR20","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.3168\/jds.2008-1189","volume":"91","author":"J Wang","year":"2008","unstructured":"Wang J, Yang P, Tang B, Sun X, Zhang R, Guo C, et al. Expression and characterization of bioactive recombinant human alpha-lactalbumin in the milk of transgenic cloned cows. J Dairy Sci. 2008;91(12):4466\u201376.","journal-title":"J Dairy Sci"},{"issue":"5","key":"446_CR21","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nbt0502-484","volume":"20","author":"PH Berkel van","year":"2002","unstructured":"van Berkel PH, Welling MM, Geerts M, van Veen HA, Ravensbergen B, Salaheddine M, et al. Large scale production of recombinant human lactoferrin in the milk of transgenic cows. Nat Biotechnol. 2002;20(5):484\u20137.","journal-title":"Nat Biotechnol"},{"issue":"10","key":"446_CR22","doi-asserted-by":"publisher","first-page":"e3453","DOI":"10.1371\/journal.pone.0003453","volume":"3","author":"P Yang","year":"2008","unstructured":"Yang P, Wang J, Gong G, Sun X, Zhang R, Du Z, et al. Cattle mammary bioreactor generated by a novel procedure of transgenic cloning for large-scale production of functional human lactoferrin. PLoS ONE. 2008;3(10):e3453.","journal-title":"PLoS ONE"},{"issue":"3","key":"446_CR23","doi-asserted-by":"publisher","first-page":"e17593","DOI":"10.1371\/journal.pone.0017593","volume":"6","author":"B Yang","year":"2011","unstructured":"Yang B, Wang J, Tang B, Liu Y, Guo C, Yang P, et al. Characterization of bioactive recombinant human lysozyme expressed in milk of cloned transgenic cattle. PLoS ONE. 2011;6(3):e17593.","journal-title":"PLoS ONE"},{"issue":"8","key":"446_CR24","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1073\/pnas.1315792111","volume":"111","author":"EW Rogier","year":"2014","unstructured":"Rogier EW, Frantz AL, Bruno MEC, Wedlund L, Cohen DA, Stromberg AJ, et al. Secretory antibodies in breast milk promote long-term intestinal homeostasis by regulating the gut microbiota and host gene expression. Proc Natl Acad Sci. 2014;111(8):3074\u20139.","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"446_CR25","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.earlhumdev.2015.08.013","volume":"91","author":"NJ Andreas","year":"2015","unstructured":"Andreas NJ, Kampmann B, Mehring Le-Doare K. Human breast milk: a review on its composition and bioactivity. Early Hum Dev. 2015;91(11):629\u201335.","journal-title":"Early Hum Dev."},{"key":"446_CR26","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/978-1-61779-433-9_34","volume":"824","author":"Z Bosze","year":"2012","unstructured":"Bosze Z, Hiripi L. Recombinant protein expression in milk of livestock species. Methods Mol Biol. 2012;824:629\u201341.","journal-title":"Methods Mol Biol"},{"issue":"2","key":"446_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cimid.2007.11.005","volume":"32","author":"L Houdebine","year":"2009","unstructured":"Houdebine L. Production of pharmaceutical proteins by transgenic animals. Comp Immunol Microbiol Infect Dis. 2009;32(2):107\u201321.","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"34","key":"446_CR28","doi-asserted-by":"publisher","first-page":"6373","DOI":"10.1016\/j.vaccine.2007.06.011","volume":"25","author":"E Soler","year":"2007","unstructured":"Soler E, Parez N, Passet B, Dubuquoy C, Riffault S, Pillot M, et al. Recombinant rotavirus inner core proteins produced in the milk of transgenic rabbits confer a high level of protection after intrarectal delivery. Vaccine. 2007;25(34):6373\u201380.","journal-title":"Vaccine."},{"issue":"2","key":"446_CR29","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/infdis\/jit166","volume":"208","author":"M Patel","year":"2013","unstructured":"Patel M, Glass RI, Jiang B, Santosham M, Lopman B, Parashar U. A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy. J Infect Dis. 2013;208(2):284\u201394.","journal-title":"J Infect Dis"},{"issue":"2","key":"446_CR30","doi-asserted-by":"publisher","first-page":"505","DOI":"10.4161\/hv.27097","volume":"10","author":"B Cheuvart","year":"2014","unstructured":"Cheuvart B, Neuzil KM, Steele AD, Cunliffe N, Madhi SA, Karkada N, et al. Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis: analysis of clinical trials of human rotavirus vaccine. Hum Vaccine Immunother. 2014;10(2):505\u201311.","journal-title":"Hum Vaccine Immunother."},{"issue":"9","key":"446_CR31","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1172\/JCI14397","volume":"109","author":"N Feng","year":"2002","unstructured":"Feng N, Lawton JA, Gilbert J, Kuklin N, Vo P, Prasad BV, et al. Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb. J Clin Invest. 2002;109(9):1203\u201313.","journal-title":"J Clin Invest."},{"issue":"21","key":"446_CR32","doi-asserted-by":"publisher","first-page":"10692","DOI":"10.1128\/JVI.00927-06","volume":"80","author":"B Corthsy","year":"2006","unstructured":"Corthsy B, Benureau Y, Perrier CM, Fourgeux C, Parez N, Greenberg H, et al. Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion. J Virol. 2006;80(21):10692\u20139.","journal-title":"J Virol"},{"issue":"1","key":"446_CR33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev.immunol.15.1.235","volume":"15","author":"MF Bachmann","year":"1997","unstructured":"Bachmann MF, Zinkernagel RM. Neutralizing antiviral B cell responses. Annu Rev Immunol. 1997;15(1):235\u201370.","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"446_CR34","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1002\/2211-5463.12267","volume":"7","author":"L Wang","year":"2017","unstructured":"Wang L, Xing D, Le Van A, Jerse AE, Wang S. Structure-based design of ferritin nanoparticle immunogens displaying antigenic loops of Neisseria gonorrhoeae. FEBS Open Bio. 2017;7(8):1196\u2013207.","journal-title":"FEBS Open Bio."},{"issue":"6","key":"446_CR35","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s11248-005-1771-0","volume":"14","author":"E Soler","year":"2005","unstructured":"Soler E, Saux ASL, Guinut FDR, Passet B, Cohen R, Merle C, et al. Production of two vaccinating recombinant rotavirus proteins in the milk of transgenic rabbits. Transgenic Res. 2005;14(6):833\u201344.","journal-title":"Transgenic Res"},{"key":"446_CR36","doi-asserted-by":"publisher","first-page":"910","DOI":"10.3389\/fpls.2017.00910","volume":"8","author":"H Feng","year":"2017","unstructured":"Feng H, Li X, Song W, Duan M, Chen H, Wang T, et al. Oral administration of a seed-based bivalent rotavirus vaccine containing VP6 and NSP4 induces specific immune responses in mice. Front Plant Sci. 2017;8:910.","journal-title":"Front Plant Sci."},{"issue":"8","key":"446_CR37","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/j.1744-7909.2005.00145.x","volume":"47","author":"JL Dong","year":"2005","unstructured":"Dong JL, Zhou B, Sheng G, Wang T. Transgenic tobacco expressing a modified VP6 gene protects mice against rotavirus infection. J Integr Plant Biol. 2005;47(8):978\u201387.","journal-title":"J Integr Plant Biol"},{"issue":"2","key":"446_CR38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.virol.2005.06.004","volume":"339","author":"J Dong","year":"2005","unstructured":"Dong J, Liang B, Jin Y, Zhang W, Wang T. Oral immunization with pBsVP6-transgenic alfalfa protects mice against rotavirus infection. Virology. 2005;339(2):153\u201363.","journal-title":"Virology"},{"issue":"2","key":"446_CR39","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1023\/A:1022912130286","volume":"12","author":"J Yu","year":"2003","unstructured":"Yu J, Langridge W. Expression of rotavirus capsid protein VP6 in transgenic potato and its oral immunogenicity in mice. Transgenic Res. 2003;12(2):163\u20139.","journal-title":"Transgenic Res"},{"key":"446_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.phrs.2016.03.002","volume":"107","author":"M Truffi","year":"2016","unstructured":"Truffi M, Fiandra L, Sorrentino L, Monieri M, Corsi F, Mazzucchelli S. Ferritin nanocages: a biological platform for drug delivery, imaging and theranostics in cancer. Pharmacol Res. 2016;107:57\u201365.","journal-title":"Pharmacol Res"},{"issue":"7","key":"446_CR41","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.bbagen.2008.09.004","volume":"1790","author":"P Arosio","year":"2009","unstructured":"Arosio P, Ingrassia R, Cavadini P. Ferritins: a family of molecules for iron storage, antioxidation and more. Biochim Biophys Acta. 2009;1790(7):589\u201399.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"446_CR42","doi-asserted-by":"crossref","first-page":"t4986","DOI":"10.1101\/pdb.prot4986","volume":"2008","author":"AH Fischer","year":"2008","unstructured":"Fischer AH, Jacobson KA, Rose J, Zeller R. Hematoxylin and Eosin staining of tissue and cell sections. Cold Spring Harb Protoc. 2008;2008(6):t4986.","journal-title":"Cold Spring Harb Protoc"},{"key":"446_CR43","volume-title":"Manipulating the mouse embryo: a laboratory manual","author":"A Nagy","year":"2003","unstructured":"Nagy A, Gertsenstein M, Vintersten K, Behringer R. Manipulating the mouse embryo: a laboratory manual. 3rd ed. New York: Firefly Books; 2003.","edition":"3"},{"issue":"6","key":"446_CR44","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/89297","volume":"19","author":"J Yu","year":"2001","unstructured":"Yu J, Langridge WH. A plant-based multicomponent vaccine protects mice from enteric diseases. Nat Biotechnol. 2001;19(6):548\u201352.","journal-title":"Nat Biotechnol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-019-0446-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12951-019-0446-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-019-0446-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T16:27:03Z","timestamp":1662827223000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-019-0446-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,22]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["446"],"URL":"https:\/\/doi.org\/10.1186\/s12951-019-0446-6","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,22]]},"assertion":[{"value":"17 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"13"}}